Osteoarthritis Therapeutics Market 2020-2024- Featuring Abbott Laboratories, Bayer AG, Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Opportunities, and Forecast 2024

The osteoarthritis therapeutics market is poised to grow by USD 2.99 bn during 2020-2024, progressing at a CAGR of almost 9% during the forecast period.

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the osteoarthritis therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the increasing incidence of osteoarthritis.

The osteoarthritis therapeutics market analysis includes product segment and geography landscape. This study identifies the availability of guidelines for disease management as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The osteoarthritis therapeutics market covers the following areas:

Osteoarthritis Therapeutics Market Sizing

Osteoarthritis Therapeutics Market Forecast

Osteoarthritis Therapeutics Market Analysis

Companies Mentioned

• Abbott Laboratories
• Anika Therapeutics Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Sanofi
• Zimmer Biomet Holdings Inc.

   

Related Reports on Health Care Include:

• Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The point of care diagnostics market size has the potential to grow by USD 10.69 billion during 2020-2024. However, the market's growth momentum will decelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
  
• Prostate Biopsy Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024- The prostate biopsy market size has the potential to grow by USD 380.23 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes

   

Key Topics Covered:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Product

• Market segments
• Comparison by Product
• Analgesics and NSAIDs - Market size and forecast 2019-2024
• Corticosteriods - Market size and forecast 2019-2024
• Viscosupplements - Market size and forecast 2019-2024
• Others - Market size and forecast 2019-2024
• Market opportunity by Product

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Drivers, Challenges, and Trends

• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Anika Therapeutics Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Sanofi
• Zimmer Biomet Holdings Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.